Atherosclerosis Research Center
The Atherosclerosis Research Center is an atherosclerotic and metabolic research center that investigates treatments for cholesterol disorders, diabetes mellitus, hypertension, obesity, and other metabolic disorders. The goals of the Center are to reduce pain, suffering and death from atherosclerosis and vascular disease. Strategies to achieve these goals include developing in vitro and animal models that emulate key aspects of human metabolism, and using these models to test hypotheses about molecular mechanisms for lipid disorders, obesity, diabetes and with the ultimate goal of translating insights into improvements in the diagnosis, prevention and treatment of vascular diseases in humans.
Both graduate and postgraduate education is important in translating new therapies into clinical practice. The Center’s research, which focuses on multiple aspects of metabolic syndromes including lipid disorders, obesity, type 2 diabetes mellitus and cardiovascular disease, is conducted through work within the Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, China. Our research team consists of research coordinators, on-site dietitians, research phlebotomists and affiliated research physicians as well as other important research personnel. Professor Ma Xin-Liang has been, and continues to be, our Director. He has been the Principal Investigator of numerous basic and clinical research trials, has given national and international presentations at scientific meetings and conferences, and is published in the medical literature.
